...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A bio investor must

Zenith had a nice bump today..Mgmt must have also watched Billions....LOL!

Share
New Message
Please login to post a reply